ESC Congress Digital Experience 2020 Conference Review

In this review:

EMPEROR-Reduced: CV and renal events with empagliflozin in HFREF
DAPA-CKD: dapagliflozin in chronic kidney disease
DAPA-HF: three analyses of dapagliflozin in HFREF: baseline risk, COPD and hyperkalaemia risk
EXPLORER-HCM: mavacamten in adults with symptomatic obstructive HCM
LoDoCo 2: colchicine in chronic coronary artery disease
POPULAR TAVI: aspirin ±clopidogrel after TAVI
VICTORIA: vericiguat in HFREF
EAST-AFNET 4: early rhythm control for AF
BPLTTC: cancer risk with antihypertensives
REALITY: transfusion strategies for post- MI anaemia

Please login below to download this issue (PDF)